Caladrius Biosciences - 48 Year Dividend Yield History | CLBS
Historical dividend payout and yield for Caladrius Biosciences (CLBS) since 1971. The current TTM dividend payout for Caladrius Biosciences (CLBS) as of February 15, 2019 is $0.00. The current dividend yield for Caladrius Biosciences as of February 15, 2019 is 0.00%.
||Medical - Biomedical and Genetics
Caladrius Biosciences, Inc. is an immunotherapy company which specializes in cell process optimization, development and manufacturing. Its product candidate consists of NBS20, a targeted cancer immunotherapy product for the treatment of metastatic melanoma; NBS10, an ischemic repair product to preserve heart muscle function following an acute myocardial infarction and NBS03D, an immune modulation product for the treatment of diabetes which are in different clinical trials. Caladrius Biosciences, Inc., formerly known as NeoStem, Inc., is headquartered in New York.